FAM23A inhibitors are a class of chemical compounds designed to interact with the FAM23A protein, a molecular entity that plays a role in cellular processes. These inhibitors function by targeting the specific interactions or signaling pathways in which FAM23A is involved. Since FAM23A is implicated in the regulation of certain intracellular activities, the inhibitors aim to attenuate the protein's function by either directly binding to it or interfering with its regulatory mechanisms, ultimately leading to the repression of FAM23A's activity within the cell.
The mode of action of FAM23A inhibitors can be diverse, ranging from the blockade of the protein's active sites to the alteration of its conformational state, thereby preventing proper function. Some inhibitors may act by disrupting the transcriptional regulation of the FAM23A gene, ensuring that the protein is not synthesized in the first place, while others might prevent post-translational modifications that are crucial for FAM23A's activity. These compounds typically exert their effects by specifically disrupting the pathways or molecular interactions that are necessary for FAM23A to carry out its role, without affecting unrelated systems within the cell. This specificity is critical to the design of FAM23A inhibitors, as it allows for targeted inhibition of the protein while minimizing off-target effects that could disrupt cellular homeostasis.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SL-327 | 305350-87-2 | sc-200685 sc-200685A | 1 mg 10 mg | $107.00 $332.00 | 7 | |
An inhibitor of MEK1/2, SL327 could suppress the MAPK/ERK pathway, which may reduce FAM23A's activation if it is associated with this pathway's signaling or regulation. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is a potent inhibitor of mTOR kinase, affecting both mTORC1 and mTORC2 complexes. By inhibiting these, AZD8055 could potentially decrease FAM23A activity if it plays a role in the mTOR signaling pathways. | ||||||